510(k) Report

510(k) · Cleared

Cleared

Virtuoso System for Ihc KI-67 (30-9)

K111755510(k) TraditionalCleared Feb 22, 2012245-day reviewClass II21 CFR 864.1860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ventana Medical Systems, Inc. · NOT Microscope, Automated, Image Analysis, Operator Intervention

Cleared on Feb 22, 2012 as substantially equivalent to K092333 (Bioimagene, Inc., 2010) after a 245-day review. Its family tree reaches back 2 generations to 2006. 2 later devices descend from it.

Decided
Feb 22, 2012
Review
245 days
Class
Class II
Product code
NOT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K053520 (2006). 3 ancestors in all. 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2015: 1 descendant cleared2013: 1 descendant clearedK053520 · Ventana Image Analysis System, Model KI-67 · Tripath Imaging, Inc. · 2006K092333 · Pathiam System with Iscan for P53 and KI-67 · Bioimagene, Inc. · 201020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants K092333 · Pathiam System with Iscan for P53 and KI-67 · Bioimagene, Inc. · 2010K053520 · Ventana Image Analysis System, Model KI-67 · Tripath Imaging, Inc. · 20060
  1. Root · 2 generations backK053520 Ventana Image Analysis System, Model KI-67Tripath Imaging, Inc. · 2006
  2. 1 generation backK092333 Pathiam System with Iscan for P53 and KI-67Bioimagene, Inc. · 2010
  3. This deviceK111755 Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc. · 2012
  4. Descendant · cites it directly · 0 of its ownK140957 Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015
  5. Descendant · cites it directly · 0 of its ownK121033 Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc. · 2013

Most influential descendants

Showing 2 of 2 · See all
  • K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015 · cites it directly0descendants
  • K121033Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K053520Ventana Image Analysis System, Model KI-67Tripath Imaging, Inc.2006—
−1K092333Pathiam System with Iscan for P53 and KI-67Bioimagene, Inc.2010—
0 (this device)K111755Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc.2012—
+1K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd.2015—
+1K121033Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201510
FIG. 1 — Lineage of K111755, 2006–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NOT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NOT device

  1. #1 K260755 OptraSCAN Systemscore 12.2 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092333Pathiam System with Iscan for P53 and KI-67
Summary page 1
…ystem with iScan for p53 and Ki-67 (Biolmagene, Inc. [now Ventana Digital Pathology], Sunnyvale, CA), cleared under pre-market notification K092333 on October 27, 2010. Both devices are digital pathology and image analysis systems for the consistent assessment o…
Bioimagene, Inc.2010—

Also cleared against K092333: 2 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd.20150
K121033Virtuoso System for Ihc KI-67 (30-9)Ventana Medical Systems, Inc.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 4.5 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K140957 (Applied Spectral Imaging, Ltd., 2015) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K092333.

How does its category compare?

All NOT devices

NOT Microscope, Automated, Image Analysis, Operator Intervention: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · NOT

1in 2014

2007: 22009: 22011: 12012: 22013: 12014: 12026 (partial year): 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NOT

Too few NOT 510(k)s in any year since 2007 to give a median.

Recalls per year · NOT

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NOT

1in 2023

2014: 12015: 12023: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code NOT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20092—00
20100—00
20111—00
20122—00
20131—00
20141—01
20150—01
20160—00
20170—00
20180—10
20190—00
20200—00
20210—00
20220—00
20230—01
20240—00
20250—00
20261—0—

What is it indicated for?

The Virtuoso system provides automated digital slide creation, management, analysis, and viewing. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting, review and classification of tissues and cells of clinical interest based on particular morphology, color, intensity, size, pattern and shape. The VirtuosoTM System for Ki67 (30-9) is for digital read and image analysis applications. This particular…

Read the full statement (308 words)

The Virtuoso system provides automated digital slide creation, management, analysis, and viewing. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting, review and classification of tissues and cells of clinical interest based on particular morphology, color, intensity, size, pattern and shape.

The VirtuosoTM System for Ki67 (30-9) is for digital read and image analysis applications. This particular Virtuoso system is intended for use as an aid to the pathologist in the detection and semi-quantitative measurement of Ki67 (30-9) protein in formalin-fixed, paraffin-embedded normal and neoplastic tissue. This device is an accessory to the Ventana Medical Systems, Inc. CONFIRMTM anti-Ki67 (30-9) Rabbit Monoclonal Primary Antibody assay. The Ventana Medical Systems, Inc. CONFIRMTM anti-Ki67 (30-9) assay is indicated for use in assessing the proliferative activity of normal and neoplastic breast tissue. When used with this assay, the VirtuoSOTM System for Ki67 (30-9) is indicated for use as an aid in the assessment of Ki-67 status in breast cancer patients (but is not the sole basis for treatment).

Note: The IHC Ki67 (30-9) Digital Read and Image Analysis applications are adjunctive computer-assisted methodologies for the qualified pathologist in the acquisition and measurement of images from microscope glass slides of breast cancer specimens stained for the presence of Ki67 protein. The pathologist should verify agreement with the Image Analysis software application score. The accuracy of the test results depends on the quality of the immunohistochemical staining. It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for the CONFIRMTM anti-Ki67 (30-9) Rabbit Monoclonal Primary Antibody assay to assure the validity of the VirtuoSOTM System for Ki67 (30-9) Digital Read and Image Analysis scores. The actual correlation of CONFIRMTM anti-Ki67 (30-9) Rabbit Monoclonal Primary antibody assay to clinical outcome has not been established.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K111755: Virtuoso System for Ihc KI-67 (30-9).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111755

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026